Category and country

CDMO companies in Poland

3 cdmo profiles in Poland. Every profile is hand-reviewed with leadership, certifications, and public sources.

Profiles3
Verified3
With certifications2
Cities3
Category view

Where does cdmo cluster in Poland?

Gdansk / Warsaw (1), Łódź (1), and Skawina (1) Most visible profiles: SyVento BioTech Sp. z o.o., Mabion S.A., and Rezon Bio.

Category view

Which standards are already visible?

GMP (2) Latest review: 24 April 2026. Review cycle: April 2026.

Full list

CDMO profiles in Poland

3 profiles match the active filter.

Current review cycle

SyVento BioTech Sp. z o.o.

SkawinaPolandCDMO

Skawina GMP-capable mRNA and lipid-nanoparticle CDMO operating on a Cytiva FlexFactory platform, covering formulation, drug substance, and drug product manufacturing from preclinical to clinical stage.

Lead
Kajetan BartosikChief Executive Officer
Scale
GMP-capable mRNA and LNP manufacturing
0 sources38d reviewGMP-capable mRNA facility on Cytiva FlexFactoryPreclinical to clinical CDMO scope
Current review cycle

Mabion S.A.

ŁódźPolandCDMO

Recombinant protein manufacturing node with Novavax-linked CDMO execution and GMP-compliant biologics infrastructure in Łódź. The verified March 2026 record captures Mabion's commercial biologics posture and end-to-end CDMO positioning.

Lead
Gregor KawaletzChief Executive Officer and President of the Management Board
Scale
Commercial biologics CDMO
0 sources79d reviewGMP-compliant biologics manufacturing
Current review cycle

Rezon Bio

Gdansk / WarsawPolandCDMO

Commercial biosimilars and mammalian cell culture platform spanning Gdansk and Warsaw under the Rezon Bio brand. Current registry record tracks the renamed Polish biologics CDMO layer through its March 2026 executive and operating surface.

Lead
Adriana Kiedzierska-MencfeldChief Executive Officer
Scale
Commercial biologics CDMO
0 sources79d reviewCommercial Biologics PlatformGMP Manufacturing
Related brief

Read deeper on this category

Market brief

European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule

Where to look for biologics, fill-finish, small-molecule, and specialised CDMO capacity across Europe in 2026 — 33 CDMOs in the directory across 9 countries, organised by what they actually do and where they sit.

Open brief
FAQ

Frequently asked questions on this category

What is a CDMO?
A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.
Which European countries have the most CDMO capacity?
Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.
How are these CDMO companies verified?
Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.
Can I compare two CDMO providers side by side?
Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.
Next step

Compare companies or open the wider market.

Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.